Type of Hip Fracture in Patients With Parkinson Disease is Associated With Femoral Bone Mineral Density


      Di Monaco M, Vallero F, Di Monaco R, Tappero R, Cavanna A. Type of hip fracture in patients with Parkinson disease is associated with femoral bone mineral density.


      To investigate the association between bone mineral density (BMD) and hip fracture type (cervical or trochanteric) in a sample of fallers with Parkinson disease (PD).


      Observational study.


      Rehabilitation hospital in Italy.


      We investigated 1040 of 1120 white fallers consecutively admitted to a rehabilitation hospital for hip fracture. Thirty-eight (3.65%) of the 1040 patients suffered from PD secondarily. Thirty-eight controls matched for sex, age, and hip fracture type were found among the 1002 non-PD fallers.


      Not applicable.

      Main Outcome Measures

      BMD was assessed by dual-energy x-ray absorptiometry at a mean ± SD of 21.9±7.5 days after fracture occurrence in the 38 PD patients and 21.6±5.9 days after fracture occurrence in the 38 controls.


      BMD assessed at total femur, trochanter, and intertrochanteric region was significantly lower in the 15 PD patients with trochanteric fractures than in the 23 with cervical fractures; the mean T score differences were 0.57 (95% confidence interval [CI], 0.07–1.08; P=.028), 0.66 (95% CI, 0.04–1.28; P=.037), and 0.63 (95% CI, 0.11–1.15; P=.019), respectively. A significant association between femoral BMD and hip fracture type was found at logistic regression after adjustment for several confounders. Results in the 38 controls were similar to those obtained in the 38 PD fallers.


      In a sample of PD fallers as in a control group of non-PD fallers, BMD levels assessed at 3 femoral sites were significantly lower in the patients who sustained trochanteric fractures than in those with cervical fractures of the hip.

      Key Words

      List of Abbreviations:

      BMD (bone mineral density), BMI (body mass index), CI (confidence interval), DXA (dual-energy x-ray absorptiometry), PD (Parkinson disease)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Archives of Physical Medicine and Rehabilitation
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Johnell O.
        • Melton 3rd, L.J.
        • Atkinson E.J.
        • O'Fallon W.M.
        • Kurland L.T.
        Fracture risk in patients with parkinsonism: a population-based study in Olmsted County, Minnesota.
        Age Ageing. 1992; 21: 32-38
        • Sato Y.
        • Kaji M.
        • Tsuru T.
        • Oizumi K.
        Risk factors for hip fracture among elderly patients with Parkinson's disease.
        J Neurol Sci. 2001; 82: 89-93
        • van Staa T.P.
        • Leufkens H.G.
        • Cooper C.
        Utility of medical and drug history in fracture risk prediction among men and women.
        Bone. 2002; 31: 508-514
        • Taylor B.C.
        • Schreiner P.J.
        • Stone K.L.
        • et al.
        Long-term prediction of incident hip fracture risk in elderly white women: study of osteoporotic fractures.
        J Am Geriatr Soc. 2004; 52: 1479-1486
        • Genever R.W.
        • Downes T.W.
        • Medcalf P.
        Fracture rates in Parkinson's disease compared with age- and gender-matched controls: a retrospective cohort study.
        Age Ageing. 2005; 34: 21-24
        • Vaserman N.
        Parkinson's disease and osteoporosis.
        Joint Bone Spine. 2005; 72: 484-488
        • Sato Y.
        • Kikuyama M.
        • Oizumi K.
        High prevalence of vitamin D deficiency and reduced bone mass in Parkinson's disease.
        Neurology. 1997; 49: 1273-1278
        • Petroni M.L.
        • Albani G.
        • Bicchiega V.
        • et al.
        Body composition in advanced-stage Parkinson's disease.
        Acta Diabetol. 2003; 40: S187-S190
        • Grimbergen Y.A.
        • Munneke M.
        • Bloem B.R.
        Falls in Parkinson's disease.
        Curr Opin Neurol. 2004; 17: 405-415
        • Wielinski C.L.
        • Erickson-Davis C.
        • Wichmann R.
        • Walde-Douglas M.
        • Parashos S.A.
        Falls and injuries resulting from falls among patients with Parkinson's disease and other parkinsonian syndromes.
        Mov Disord. 2005; 20: 410-415
        • Fink H.A.
        • Kuskowski M.A.
        • Orwoll E.S.
        • Cauley J.A.
        • Ensrud K.E.
        • Osteoporotic Fractures in Men (MrOS) Study Group
        Association between Parkinson's disease and low bone density and falls in older men: the osteoporoic fractures in men study.
        J Am Geriatr Soc. 2005; 53: 1559-1564
        • Winogrodzka A.
        • Wagenaar R.C.
        • Booij J.
        • Wolters E.C.
        Rigidity and bradykinesia reduce interlimb coordination in Parkinsonian gait.
        Arch Phys Med Rehabil. 2005; 86: 183-189
        • Di Monaco M.
        • Vallero F.
        • Di Monaco R.
        • Tappero R.
        • Cavanna A.
        Bone mineral density in hip-fracture patients with Parkinson's disease: a case-control study.
        Arch Phys Med Rehabil. 2006; 87: 1459-1462
        • Herman T.
        • Giladi N.
        • Gruendlinger L.
        • Hausdorff J.M.
        Six weeks of intensive treadmill training improves gait and quality of life in patients with Parkinson's disease: a pilot study.
        Arch Phys Med Rehabil. 2007; 88: 1154-1158
        • Ebersbach G.
        • Edler D.
        • Kaufhold O.
        • Wissel J.
        Whole body vibration versus conventional physiotherapy to improve balance and gait in Parkinson's disease.
        Arch Phys Med Rehabil. 2008; 89: 399-403
        • Schott A.M.
        • Hans D.
        • Duboeuf F.
        • et al.
        Quantitative ultrasound parameters as well as bone mineral density are better predictors of trochanteric than cervical hip fractures in elderly women.
        Bone. 2005; 37: 858-863
        • Di Monaco M.
        • Di Monaco R.
        • Mautino F.
        • Cavanna A.
        Femur bone mineral density, age and fracture type in 300 hip-fractured women.
        Aging Clin Exp Res. 2002; 14: 47-51
        • Di Monaco M.
        • Vallero F.
        • Di Monaco R.
        • Tappero R.
        • Cavanna A.
        Hip-fracture type does not affect the functional outcome after acute in-patient rehabilitation: a study of 684 elderly women.
        Eura Medicophys. 2007; 43: 439-444
        • Vega E.
        • Mautalen C.
        • Gómez H.
        • Garrido A.
        • Melo L.
        • Sahores A.
        Bone mineral density in patients with cervical and trochanteric fractures of the proximal femur.
        Osteoporos Int. 1991; 1: 81-86
        • Stewart A.
        • Porter R.W.
        • Primrose W.R.
        • Walker L.G.
        • Reid D.M.
        Cervical and trochanteric hip fractures: bone mass and other parameters.
        Clin Rheumatol. 1999; 18: 201-206
        • Mautalen C.
        • Vega E.
        • Einhorn T.
        Are the etiologies of cervical and trochanteric hip fractures different?.
        Bone. 1996; 18: 133-137
        • Uitewaal P.
        • Lips P.
        • Netelenbos J.
        An analysis of bone structure in patients with hip fracture.
        Bone Min. 1987; 3: 63-73
        • Idjadi J.A.
        • Aharonoff G.B.
        • Su H.
        • et al.
        Hip fracture outcomes in patients with Parkinson's disease.
        Am J Orthop. 2005; 34: 341-346
        • Di Monaco M.
        • Vallero F.
        • Di Monaco R.
        • Mautino F.
        • Cavanna A.
        Functional recovery and length of stay after hip fracture in patients with neurologic impairment.
        Am J Phys Med Rehabil. 2003; 82: 143-148
        • Jonsson B.
        • Sernbo I.
        • Johnell O.
        Rehabilitation of hip fracture in patients with Parkinson's disease.
        Scand J Rehabil Med. 1995; 27: 227-230
        • de Rijk M.C.
        • Launer L.J.
        • Berger K.
        • et al.
        Prevalence of Parkinson's disease in Europe: a collaborative study of population-based cohorts.
        Neurology. 2000; 54: S21-S23
        • MacLean C.
        • Newberry S.
        • Maglione M.
        • et al.
        Systematic review: comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis.
        Ann Intern Med. 2008; 148: 197-213
        • Sato Y.
        • Iwamoto J.
        • Kanoko T.
        • Satoh K.
        Alendronate and vitamin D2 for prevention of hip fracture in Parkinson's disease: a randomized controlled trial.
        Mov Disord. 2006; 21: 924-929
        • Sato Y.
        • Honda Y.
        • Iwamoto J.
        Risedronate and ergocalciferol prevent hip fracture in elderly men with Parkinson disease.
        Neurology. 2007; 68: 911-915
        • Sato Y.
        • Kaji M.
        • Tsuru T.
        • Satoh K.
        • Kondo I.
        Vitamin K deficiency and osteopenia in vitamin D-deficient elderly women with Parkinson's disease.
        Arch Phys Med Rehabil. 2002; 83: 86-91
        • Di Monaco M.
        • Vallero F.
        • Di Monaco R.
        • Mautino F.
        • Cavanna A.
        Serum levels of 25-hydroxy vitamin D and functional recovery after hip fracture.
        Arch Phys Med Rehabil. 2005; 86: 64-68
        • Bischoff-Ferrari H.A.
        • Giovannucci E.
        • Willett W.C.
        • Dietrich T.
        • Dawson-Hughes B.
        Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes.
        Am J Clin Nutr. 2006; 84 ([published erratum appears in Am J Clin Nutr 2006;84:1253]): 18-28
        • Perez-Lopez F.R.
        Vitamin D and its implications for muscoloskeletal health in women: an update.
        Maturitas. 2007; 58: 117-137
        • Newmark H.L.
        • Newmark J.
        Vitamin D and Parkinson's disease—a hypothesis.
        Mov Disord. 2007; 22: 461-468
        • Kanis J.A.
        • Gluer C.
        An update on the diagnosis and assessment of osteoporosis with densitometry.
        Osteoporosis Int. 2000; 11: 192-202
        • Kanis J.A.
        • Johnell O.
        • Oden A.
        • Dawson A.
        • De Laet C.
        • Jonsson B.
        Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds.
        Osteoporos Int. 2001; 12: 989-995
        • Sato Y.
        • Iwamoto J.
        • Kanoko T.
        • Satoh K.
        Homocysteine as a predictive factor for hip fracture in elderly women with Parkinson's disease.
        Am J Med. 2005; 118: 1250-1255
        • Fox K.M.
        • Magaziner J.
        • Hawkes W.G.
        • et al.
        Loss of bone density and lean body mass after hip fracture.
        Osteoporos Int. 2000; 11: 31-35
        • Di Monaco M.
        • Vallero F.
        • Di Monaco R.
        • Tappero R.
        • Cavanna A.
        Fat mass and skeletal muscle mass in hip fracture women: a cross sectional study.
        Maturitas. 2007; 56: 404-410
        • Di Monaco M.
        • Vallero F.
        • Di Monaco R.
        • Tappero R.
        • Cavanna A.
        Skeletal muscle mass, fat mass, and hip bone mineral density in elderly women with hip fracture.
        J Bone Miner Metab. 2007; 25: 237-242
        • Di Monaco M.
        • Vallero F.
        • Di Monaco R.
        • Mautino F.
        • Cavanna A.
        Body composition and hip fracture type in elderly women.
        Clin Rheumatol. 2004; 23: 6-10